Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 3,524† | 3,071† | 3,761† | 3,941† | 3,259† |
| Net profit | 401 | 319 | 436 | 499 | 387† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Harsha Chigurupati | Executive Director | June 30, 2026 |
| Krishna Prasad Chigurupati | Executive Director | June 30, 2026 |
| Priyanka Chigurupati | Executive Director | June 30, 2026 |
| Uma Devi Chigurupati | Executive Director | June 30, 2026 |
| Arun Sawhney | Independent Director | June 30, 2026 |
| Kapil Kumar Mehan | Independent Director | June 30, 2026 |
| Rajiv Pritidas Kakodkar | Independent Director | June 30, 2026 |
| Saumen Chakraborty | Independent Director | June 30, 2026 |
| Sethurathnam Ravi | Independent Director | June 30, 2026 |
| Sucharita Rao Palepu | Independent Director | June 30, 2026 |
| K. B. Sankar Rao | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
